Cargando…
Serum levels of soluble receptor for advanced glycation end products and of S100 proteins are associated with inflammatory, autoantibody, and classical risk markers of joint and vascular damage in rheumatoid arthritis
INTRODUCTION: The receptor for advanced glycation end products (RAGE) is a member of the immunoglobulin superfamily of cell surface receptor molecules. High concentrations of three of its putative proinflammatory ligands, S100A8/A9 complex (calprotectin), S100A8, and S100A12, are found in rheumatoid...
Autores principales: | Chen, Yueh-Sheng, Yan, Weixing, Geczy, Carolyn L, Brown, Matthew A, Thomas, Ranjeny |
---|---|
Formato: | Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2009
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2688185/ https://www.ncbi.nlm.nih.gov/pubmed/19284577 http://dx.doi.org/10.1186/ar2645 |
Ejemplares similares
-
Receptor for advanced glycation end products Glycine 82 Serine polymorphism and risk of cardiovascular events in rheumatoid arthritis
por: Carroll, Lisa, et al.
Publicado: (2007) -
Joint damage is amplified in rheumatoid arthritis patients with positive thyroid autoantibodies
por: Chen, Yu-Lan, et al.
Publicado: (2018) -
Low Soluble Receptor for Advanced Glycation End Products Precedes and Predicts Cardiometabolic Events in Women With Rheumatoid Arthritis
por: Nadali, Mitra, et al.
Publicado: (2021) -
Integrative Mendelian randomization reveals the soluble receptor for advanced glycation end products as protective in relation to rheumatoid arthritis
por: Lee, Gha Young, et al.
Publicado: (2023) -
Decreased levels of soluble receptor for advanced glycation end products in patients with rheumatoid arthritis indicating deficient inflammatory control
por: Pullerits, Rille, et al.
Publicado: (2005)